- Home
- NCSM vs LVTX Comparison
NCSM vs LVTX Comparison
Compare NCSM & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- LVTX
- Stock Information
- Founded
- NCSM 2006
- LVTX 2016
- Country
- NCSM United States
- LVTX Netherlands
- Employees
- NCSM N/A
- LVTX N/A
- Industry
- NCSM Oilfield Services/Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- LVTX Health Care
- Exchange
- NCSM Nasdaq
- LVTX Nasdaq
- Market Cap
- NCSM 79.3M
- LVTX 33.9M
- IPO Year
- NCSM 2017
- LVTX 2021
- Fundamental
- Price
- NCSM $30.05
- LVTX N/A
- Analyst Decision
- NCSM
- LVTX Hold
- Analyst Count
- NCSM 0
- LVTX 3
- Target Price
- NCSM N/A
- LVTX $1.75
- AVG Volume (30 Days)
- NCSM 8.3K
- LVTX 12.3K
- Earning Date
- NCSM 07-30-2025
- LVTX 08-19-2025
- Dividend Yield
- NCSM N/A
- LVTX N/A
- EPS Growth
- NCSM N/A
- LVTX N/A
- EPS
- NCSM 3.27
- LVTX N/A
- Revenue
- NCSM $168,704,000.00
- LVTX $4,990,000.00
- Revenue This Year
- NCSM $7.17
- LVTX N/A
- Revenue Next Year
- NCSM $5.44
- LVTX N/A
- P/E Ratio
- NCSM $9.20
- LVTX N/A
- Revenue Growth
- NCSM 18.16
- LVTX N/A
- 52 Week Low
- NCSM $15.90
- LVTX $0.85
- 52 Week High
- NCSM $38.95
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- NCSM 45.67
- LVTX 52.45
- Support Level
- NCSM $28.73
- LVTX $1.27
- Resistance Level
- NCSM $33.88
- LVTX $1.38
- Average True Range (ATR)
- NCSM 1.24
- LVTX 0.04
- MACD
- NCSM -0.17
- LVTX -0.00
- Stochastic Oscillator
- NCSM 25.24
- LVTX 44.64
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.